Location History:
- Montrouge, FR (2008)
- Montrogue, FR (2014)
Company Filing History:
1 out of 1 
1 out of 319 
1 out of 1,744 
Years Active: 2008-2014
Title: The Innovations of James Chloe
Introduction
James Chloe is a notable inventor based in Montrogue, France. He has made significant contributions to the field of medical diagnostics, particularly concerning mutations related to myeloproliferative disorders. With a total of 2 patents, his work has had a profound impact on the understanding and diagnosis of certain blood-related conditions.
Latest Patents
James Chloe's latest patents include the identification of a JAK2 mutation involved in Vaquez Polyglobulia. This invention focuses on the V617F variant of the protein-tyrosine kinase JAK2, which is responsible for Vaquez Polyglobulia. The invention also introduces a first intention diagnostic method for erythrocytosis and thrombocytosis, allowing their association with myeloproliferative disorders. Additionally, it facilitates the detection of the JAK2 V617F variant in these disorders, enabling their reclassification into a new nosological group. Another significant patent by Chloe is the identification of a JAK2 mutation in Polycythemia Vera, which shares similar diagnostic implications.
Career Highlights
Throughout his career, James Chloe has worked with reputable organizations such as Ipsogen and Assistance Publique-Hôpitaux de Paris. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medical science.
Collaborations
James Chloe has collaborated with notable professionals, including William Vainchenker and Jean-Pierre Le Couedic. These partnerships have played a crucial role in advancing his research and innovations.
Conclusion
James Chloe's work in identifying JAK2 mutations has significantly advanced the field of medical diagnostics. His contributions continue to influence the understanding and treatment of myeloproliferative disorders.